EPO has been used to reduce vasospasm in sub-arachnoid haemorrhage in a randomized controlled trial, which was associated with reduced DIND with new cerebral infarcts, a reduction of impaired auto-regulation and better outcome at discharge [61]. Here, EPO is linked to cerebral infarction.